- Service Name
TrueBinding Inc.
- Industry
Biotechnology, biotherapeutics, clinical research, monoclonal antibodies
- Main Value Proposition
TrueBinding offers targeted and effective treatments for a range of serious medical conditions, enhancing patient outcomes through precision medicine.
- Description
TrueBinding Inc. is a clinical stage biotherapeutic company focused on developing novel monoclonal antibody therapeutics for neurodegenerative and metabolic diseases, stroke, and oncology. The company aims to address significant unmet medical needs through innovative treatments.
- Key Features
Development of monoclonal antibody therapeutics; Expanded Access Program for compassionate use; Accelerated biopharmaceutical innovation; Clinical trials for various diseases including Alzheimer's and Parkinson's
- Use Cases
The service is most valuable in scenarios involving patients with Alzheimer's Disease, Parkinson's Disease, and Autism Spectrum Disorder, particularly those who have exhausted other treatment options.
- Competitive advantages
Rapid and efficient production of high-quality therapeutics; Access to investigational medications through the Expanded Access Program; Strong focus on precision medicine and patient-centered care
- Strengths
TrueBinding's strengths lie in its innovative approach to drug development, commitment to addressing unmet medical needs, and the establishment of a robust pipeline of therapeutics.
- Positioning
TrueBinding positions itself as a leader in the biotherapeutics space, focusing on innovative solutions for complex medical challenges.
- Audience
The target users include patients suffering from neurodegenerative diseases, healthcare providers seeking innovative treatment options, and biopharmaceutical companies looking for contract development services.
- CTA
Learn More About Us, View Our Pipeline, TB006 Expanded Access
- Tags
biotherapeutics
monoclonal antibodies
clinical trials
precision medicine
- Tagline
Revolutionizing Patient Care
- Tone of Voice
Innovative, compassionate, professional
- Differentiation
TrueBinding stands out in the market by combining advanced technology with a focus on rapid development and delivery of monoclonal antibodies, specifically tailored for neurodegenerative and metabolic diseases.
- Brand Positioning
The brand identity of TrueBinding emphasizes innovation, compassion, and a commitment to improving patient care through advanced therapeutic solutions.
- Founded
2015-01-01
- Founders
Dongxu Sun